Traditional Chinese medicine injections: where we are after 80-year development-Reference-Cited by-同舟云学术

Traditional Chinese medicine injections: where we are after 80-year development

Published:2022-11-08 Issue:1 Volume:17 Page:
ISSN:1749-8546
Container-title:Chinese Medicine
language:en
Short-container-title:Chin Med

Author:

Zheng Wenwen,Wu Yiyang,Gao Hanlu,Ouyang Defang

Abstract

AbstractTraditional Chinese medicine (TCM) injection is the combination of modern pharmaceutical technology and traditional Chinese prescription, which was born in 1941 and played a great role in the backward medical conditions at that time. However, the debate over TCM injections has never stopped due to adverse drug reactions (ADRs). The regulation on TCM injections has been further strengthened since 2017, which has prompted many TCM injections to carry out re-evaluations on quality, safety, efficiency as well as pharmacoeconomics, which made significant changes and progress. This review presented an up-to-date analysis of the types, amounts, and ADRs of TCM injections based on the published data and literature. This review also summarized the potential reasons for the ADRs and re-evaluation strategies. This review will provide some useful clues for TCM injections and their clinical use.

Funder

the Science and Technology Development Fund

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,Pharmacology

Link

https://link.springer.com/content/pdf/10.1186/s13020-022-00681-w.pdf

Reference50 articles.

1. Tan L, Wang M, Zhu Y. Research progress of adverse reactions of traditional Chinese medicine injections. China J Chin Mater Med. 2014;39:3889–98 (in Chinese).

2. Xu L, Liu J, Zou L. Current situation analysis and prospects of traditional Chinese medicine injection. J Chengdu Univ Technol (Sci Technol Ed). 2013;32:215–8 (in Chinese).

3. Bai X. An analysis of the current situation and countermeasures for the development of traditional Chinese herbal injection. Pharmacol Clin Chin Mater Med. 2008;24:67–9 (in Chinese).

4. Ji K, Chen J, Li M, Liu Z, Xia L, Wang C, et al. Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections. Regul Toxicol Pharmacol. 2009;55:134–8.

5. Notice on printing and distributing basic technical requirements for traditional Chinese medicine and natural medicine injections. 2007. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20071206120001186.html. Accessed 30 July 2022 (in Chinese).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mechanism of Catalpol to Improve Oxidative Damage of Dermal Fibroblasts Based on Nrf2/HO-1 Signaling Pathway;Drug Design, Development and Therapy;2024-06

2. Safflower yellow in Carthami Flos is responsible for Xuebijing Injection-induced immediate hypersensitivity reaction through activating complement C3;Chinese Herbal Medicines;2024-06

3. Traditional Chinese medicine for neonatal hypoxic-ischemic encephalopathy: A Bayesian network meta-analysis;Journal of Ethnopharmacology;2024-01

4. Potential Involvement of Organic Anion Transporters in Drug Interactions with Shuganning Injection, a Traditional Chinese Patent Medicine;Planta Medica;2023-05-26

5. Safflower Yellow in Carthami Flos is Responsible for Xuebijing Injection-Induced Immediate Hypersensitivity Reaction Through Activating Complement C3;2023